Open AccessPB2353: HEALTHCARE RESOURCE UTILIZATION AND COSTS OFF THERAPY WITH FIXED‐DURATION VENETOCLAX AMONG CLL PATIENTS
Author(s) -
Allan J. N.,
Skarbnik A. P.,
Emechebe N.,
Alhasani H.,
Manzoor B. S.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000852236.17476.58
Subject(s) - venetoclax , medicine , obinutuzumab , interquartile range , context (archaeology) , chronic lymphocytic leukemia , rituximab , oncology , leukemia , lymphoma , paleontology , biology